ArticleJournal of the National Comprehensive Cancer Network : JNCCN2023

Nationwide Trends and Determinants of Germline BRCA1/2 Testing in Patients With Breast and Ovarian Cancer.

Kelsey S Lau-Min et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.